EUGIA Pharma Specialities Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Unit-1, Sy. No. 550, 551 & 552, Kolthur Village, Shamirpet Mandal, Medchal-Malkajgiri, Telangana 500101, India (IND)
- Operations here
- analysismanufacturepack
- FDA identifiers
- FEI 3011960448 · DUNS 872201704
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2023-07-26
- VAIDrug Quality Assurance2022-11-25
Drugs this plant is listed as making
36 distinct drugs across 95 products name this site in their FDA label.
- AnastrozoleAurobindo Pharma Limited
- Azacitidinein shortageEugia US LLC
- Bendamustine HydrochlorideEugia US LLC
- BortezomibEugia US LLC
- BusulfanEugia US LLC
- Carboplatinin shortageEugia US LLC
- ClofarabineEugia US LLC
- CyclophosphamideEugia US LLC
- DactinomycinEugia US LLC
- DasatinibAurobindo Pharma Limited
- DecitabineEugia US LLC
- DocetaxelEugia US LLC
- ErlotinibAurobindo Pharma Limited
- everolimusAurobindo Pharma Limited
- ExemestaneAurobindo Pharma Limited
- FluorouracilEugia US LLC
- FulvestrantEugia US LLC
- Imatinib MesylateBluePoint Laboratories
- Irinotecan HydrochlorideEugia US LLC
- LenalidomideAurobindo Pharma Limited
- LetrozoleAurobindo Pharma Limited
- Leuprolide AcetateEugia US LLC
- Medroxyprogesterone AcetateEugia US LLC
- MesnaEugia US LLC
- Methotrexatein shortageEugia US LLC
- MitomycinEugia US LLC
- OxaliplatinEugia US LLC
- PazopanibAurobindo Pharma Limited
- PemetrexedBluePoint Laboratories
- PlerixaforEugia US LLC
- PomalidomideAurobindo Pharma Limited
- ProgesteroneAurobindo Pharma Limited
- Sunitinib MalateAurobindo Pharma Limited
- Tamoxifen CitrateAurobindo Pharma Limited
- Testosterone CypionateEugia US LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.